Thermo Fisher Scientific Extends Latin America Network with new Chilean Partner for Informatics
News Apr 30, 2008
The new distribution agreement allows Alta Tecnología to support sales activities in Chile, Paraguay, Uruguay and Bolivia for the Thermo Scientific portfolio of informatics products which are focused on the process industries and analytical laboratories, including Nautilus LIMS™, Sample Manager LIMS™ and Atlas CDS™.
Dedicated sales experts will target those industries which are strong in the region, and which Thermo Fisher Scientific has long served, including the mining, pharmaceutical, petrochemical and chemical markets.
Oliver Faidi Cortes, director of sales in Latin America & Caribbean Thermo Fisher Scientific, comments, “With distributors already located strategically across Latin America, this new partnership demonstrates our commitment to further expanding and improving our services in this geography. Headquartered in Santiago de Chile, Alta Tecnología has developed a deep knowledge of local businesses across Chile, Bolivia, Paraguay and Uruguay, and the Thermo Scientific Informatics products through training. This perfectly positions Alta Tecnología to further promote and support our informatics portfolio for both new and existing customers.”
Gonzalo Gonzalez, of Alta Tecnología, confirms, “Alta Tecnología focuses on the Latin American market, currently specializing in mass spectroscopy, spectroscopy and elemental analysis. We already represent Thermo Fisher Scientific in Uruguay, Paraguay and Bolivia for mass spectrometry; chromatography; spectroscopy and elemental analysis products; and are responsible for the spectroscopy products (UV-VIS and IR) in Chile. Alta Tecnología will offer sales and technical support for the informatics portfolio, bringing a dedicated local approach to the Thermo Fisher activity in the region.”
Old age is the greatest risk factor for many diseases, including Alzheimer's disease (AD) and cancer. Geroprotectors are a recently identified class of anti-aging compounds. New research has now identified a unique subclass of these compounds, dubbed geroneuroprotectors (GNPs), which are AD drug candidates and slow the aging process in mice.READ MORE